[Disodium cromoglycate--mast cell degranulation blocker in the process of tissue remodelation].
Disodium cromoglycate (DSCG) is a compound commonly used in the treatment of allergic diseases. The effect of DSCG is due to its ability to stabilize the mast cell membrane and to prevent release of histamine and inflammatory mediators. Mast cells are also an abundant source of tissue metalloproteinases, serine proteases and growth factors, which play an important role in the processes of the tissue remodeling. In this view the DSCG is a substance which allows us to study the mechanisms of the pulmonary vascular bed remodeling in the experimental animals exposed to chronic hypoxia and in a phase of the recovery from hypoxia.
Ustav patologické fyziologie, 2. LF UK, Praha. hana.maxova@lfmotol.cuni.cz
H
H
Maxová
M
M
Vasilková
J
J
Tkaczyk
M
M
Vízek
D056151:Airway Remodeling / Q000187:drug effects*; D000818:Animals; D018927:Anti-Asthmatic Agents / Q000494:pharmacology*; D015550:Cell Degranulation / Q000187:drug effects*; D004205:Cromolyn Sodium / Q000494:pharmacology*; D006976:Hypertension, Pulmonary / Q000473:pathology / Q000503:physiopathology*; D066298:In Vitro Techniques; D008407:Mast Cells / Q000187:drug effects* / Q000502:physiology; D011651:Pulmonary Artery / Q000473:pathology; D051381:Rats
D018927:Anti-Asthmatic Agents; D004205:Cromolyn Sodium